US Stock Market Closed

Dashboard

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity

B

Analyst Opinion

B

Leverage & Liquidity

S

Fundamental Variables

H

Rating Performance

FV Performance

About

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

CEO

Vasant Narasimhan

Employees

103,914

Industry

-

Sector

-

Headquarters

Basel

Exchange

New York Stock Exchange

Summary Stats

Market Cap

197B

Revenue

53B

Net Income

24.2B

EPS

$10.73

Price-to-Earnings

7.63

Price-to-Book

3.2

Debt-to-Equity

1.04

News

Analyst Ratings

Price targets projected by 20 analysts

High

$126.00

Average

$105.79

Low

$82.00

Ratings calculated by 25 analysts

Buy

18

Hold

5

Sell

2

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q1 2022

Last Earnings

Above by $0.02

Actual

$1.46 +1.4%

Consensus

1.44

Report Date

Year Ago

1.52

Year Ago Change %

Down 3%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites